Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drugFirst approved 2018

Zumandimine(Ethinyl Estradiol/Drospirenone)Aurobindo Pharma Limited logoAUROPHARMA.NS

Medicare prescription drug cost, prescriptions and prescribers, 2024 · made by Aurobindo Pharma Limited

$8,364

Medicare cost, 2024

Medicare drug plans spent $8,364 on Zumandimine (ethinyl estradiol/drospirenone) in 2024, for 222 prescriptions and refills filled by 94 patients. New York accounts for the most spending ($1,042, 12% of the total). It is made by Aurobindo Pharma Limited (AUROPHARMA.NS).

Medicare cost, 2024

$8,364

+0.1% from 2023

Prescriptions

222

$37.67 per claim

Patients

94

98 prescribers

Total spending, 2024

$8,364

$88.98 per patient

Questions and answers

How much does Medicare spend on Zumandimine?

Medicare prescription drug plans paid $8,364 for Zumandimine in 2024, for 222 prescriptions and refills to 94 patients (up 0.1% from 2023). The average cost per claim was $37.67.

Which state spends the most on Zumandimine?

New York had the highest Medicare cost for Zumandimine in 2024: $1,042 for 19 claims, followed by Colorado ($1,021).

Who prescribes Zumandimine the most?

Laurie Miller, family practice in Fort Collins, CO, had the highest Medicare cost for Zumandimine in 2024: 11 claims costing $623.

Who makes Zumandimine?

Zumandimine is made by Aurobindo Pharma Limited (AUROPHARMA.NS), listed in the Medicare spending data as Aurobindo Pharm.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Zumandimine was $8,364 in 2024, after a high of $27K in 2021.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Zumandimine, 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
Laurie Miller Fort Collins, COFamily Practice11Under 11$623

Prescriber data by year

YearPrescribersClaimsPatientsCost
2022152468139$21K
20236724164$8,352
20249822294$8,364

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Aurobindo PharmAUROPHARMA.NS logoAUROPHARMA.NS222$8,364

Medicaid spending by quarter

Amount reimbursed by state Medicaid programs, all states

Amount reimbursed

Codes

National drug codes (packages)
4
RxNorm concept IDs
2045196, 284207, 748797, 748800
Application numbers
ANDA209407

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube